British-Swedish pharmaceutical company AstraZeneca has sought permission from Pakistan to register its COVID-19 vaccine in the country. Geo News Reported Thursday, citing sources.
A local pharmaceutical company has submitted AstraZeneca vaccine data to the Drug Regulatory Authority of Pakistan (DRP).
The Oster Zenica / Oxford vaccine, first approved by the UK in late December, is cheaper and easier to use than some competing shots, thus providing greater benefits in dealing with the epidemic that has plagued the world by 1.8. More than a million lives have been claimed.
However, there has been uncertainty about its most effective dose since data published in November showed that the success rate of the whole dose after half a dose is 90% while two full shots 62% were effective.
Two days ago, Dr. Faisal Sultan, Special Assistant to the Prime Minister for National Health Services, Regulations and Liaison, said that Pakistan hopes to receive the first shipment of COVID-19 vaccine from a Chinese synophore “in early February”. ۔
Pakistan has said it will buy 1.2 million Covid-19 vaccine drugs from Sinofirm in the first official confirmation of the purchase of the vaccine last month as the country is battling a second wave of infection.
“We expect to receive quantities of the vaccine from Sinofirm in the first quarter of this year, hopefully starting in early February,” Dr Sultan told Arab News. The first quarter of this year.
“We expect to be vaccinated in the first quarter. He said 1.1 million doses are in the first phase alone.